"Nucleus Network runs early-stage clinical trials for some of the world’s leading pharmaceutical companies in Melbourne. We are always looking for healthy volunteers from all walks of life. You can make a difference by assisting with the research of new medicines and be reimbursed up to $480 per day for your valuable time."

During the past decade, Nucleus Network conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nucleus Network" #1 sponsor was "Anavex Life Sciences Corp." with 2 trials, followed by "Prana Biotechnology Limited" with 2 trials sponsored, "RANI Therapeutics" with 2 trials sponsored, "Alder Biopharmaceuticals, Inc." with 1 trials sponsored and "Alector Inc." with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nucleus Network" #1 collaborator was "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator, "Sanofi" with 1 trials as a collaborator and "Shanghai Novamab Biopharmaceuticals Co. Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Nucleus Network" are "Healthy Volunteers" (6 trials), "Healthy" (3 trials), "Alzheimer's Disease" (2 trials), "Alzheimer Disease" (1 trials) and "Asthma" (1 trials). Many other conditions were trialed in "Nucleus Network" in a lesser frequency.

Most popular intervention types in "Nucleus Network" are "Drug" (14 trials), "Biological" (7 trials), "Other" (6 trials) and "Combination Product" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "3% SPL7013 Gel (VivaGel)" (1 trials), "30 micrograms Nexvax2" (1 trials), "60 micrograms Nexvax2" (1 trials) and "9 micrograms Nexvax2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nucleus Network" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Nucleus Network". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Nucleus Network, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nucleus Network, 17 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".